BTK downregulation is responsible for X-linked agammaglobulinemia (XLA), a severe primary immunodeficiency condition caused by mutations in the BTK gene, which inhibits precursor B-cells in the bone marrow from maturing, resulting in B lymphocyte insufficiency and infection vulnerability [42,43]. Here, BTK is linked to immunodeficiency disease.